| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2014-03-06 13:45:27 |
| Periods | |
| Versijas komentārs | |
| Teksts |
Olainfarm will Hold Fourth Quarter 2013 Investor Conference WebinarAS „Olainfarm” invites shareholders, investors, mass media representatives and other stakeholders to join its fourth quarter 2013 investor conference webinar scheduled on March 11, 2014 at 16:00 (EET). Webinar will be hosted by the member of the management board Salvis Lapiņš. The presentation will be in English. During the webinar Salvis Lapiņš will inform about AS “Olainfarm” latest activities and analyse the unaudited financial results of the year 2013. After the presentation investors will be welcomed to ask questions. Due to the limited webinar time, please send in your questions in advance till March 10 to e-mail: ieva.kadakovska@nasdaqomx.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar A/s OlainFarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information
prepared by: |
| Pielikumi |
|